Acetylsalicylic acid as an anti-platelet agent: what forms should be used, according to evidence-based medicine?
This analytic paper reviews the evidence on effectiveness, benefits and limitations of one of the best-studied antiplatelet agents – acetylsalicylic acid (ASA). The results of clinical trials, together with so called “gastro-toxicity” of ASA, or Aspirin, and a need for long-term anti-platelet therap...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2010-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2043 |